Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobuline induction in adult DCD kidney transplant recipients
ChiCTR-OIN-17011174Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of antithymocyte globulin rabbit in end-stage kidney disease (ESKD) and kidney allograft rejection, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Started Jun 2017; status: recruiting.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
end-stage kidney disease (ESKD)kidney allograft rejection
Beyond the preview
Go deeper on ChiCTR-OIN-17011174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17011174.